Loading
A phase 2 trial in colorectal cancer, run by Peking University Cancer Hospital & Institute, not yet recruiting.
Retlirafusp Alfa Plus Targeted Therapy and Chemotherapy for Unresectable Colorectal Liver-Limited Metastases is a phase 2, interventional study registered as NCT07815288 by Peking University Cancer Hospital & Institute, with a registry enrolment figure of 80 participants, started 2026-09-30 and due to reach its primary completion in 2029-12-30. Interventions recorded: Retlirafusp alfa Combined with Targeted Therapy and Chemotherapy. Conditions listed: Colorectal Adenocarcinoma Metastatic in the Liver. Primary outcome: Objective Response Rate. Colorectal eligibility wording from the registry: "Histopathologically confirmed colorectal adenocarcinoma; liver metastasis confirmed by pathology or imaging". Sites: China. No results are recorded here; the registry entry is the source.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.